PARIS, FRANCE., Dr. Michael Mullen, Cardiologist St. Bartholemews Hospital, London and Dr. Yuriy Pya,CEO and Chief of the National Research Center for Cardiac Surgery (NRCCS), Astana, Kazakhstan, ...
November 10, 2011 (San Francisco) — Quality-of-life (QoL) data from the PARTNER A trial should prompt a "rethink" of how many transcatheter aortic-valve implantations (TAVI) are performed via the ...
May 18, 2012 (Paris, France) — Early data from the SOURCE XT registry on high-risk patients treated with the Sapien XT (Edwards Lifesciences) transcatheter aortic valve show that this next-generation ...
Mitral valve replacement is where an artificial prosthetic valve (bioprosthetic or mechanical) is inserted by open heart surgery. It is most commonly done for severe symptomatic mitral regurgitation ...
The mitral valve allows blood to flow from the left atrium to the left ventricle. Mitral valve regurgitation happens when the valve does not close properly and blood flows back into the atrium from ...
Transapical access is based on decades of clinical experience with de-airing the heart, through the tip (apex) of the left ventricle, during routine cardiac surgical interventions. Insertion of a ...
Transcatheter aortic valve replacement (TAVR) by the transaortic route may result in less bleeding and fewer vascular complications than the transapical route, rendering the former technique ...
Micro Interventional Devices, Inc.™ (MID), the world leader in minimally invasive and catheter-based compliant fixation technologies addressing structural heart disease announced today that it ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Among patients who underwent transcatheter valve-in-valve repair of a failed surgical mitral ...
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the first patient implant of its 23 mm Portico™ Transcatheter Aortic Heart Valve ...
NEW ORLEANS — In this video exclusive, Fenton McCarthy, MD, from the University of Pennsylvania, discusses how outcomes from TAVR may differ based on site of access. “The important clinical questions ...
Transcatheter aortic valve implantation has evolved as a viable therapeutic option for high-risk, elderly patients with symptomatic aortic stenosis in select cardiac centers with experience of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback